UIM6:F:F-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 537.06

Change

0.00 (0.00)%

Market Cap

USD 0.66B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.11 (+0.41%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.23 (+0.45%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.88 (-0.32%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.05 (+0.30%)

USD 54.47B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.01 (0.00%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.45 (+0.62%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.89B
0ZC:F Zscaler Inc

+2.38 (+1.25%)

USD 37.92B

ETFs Containing UIM6:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 28.58% 88% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.58% 86% B+ 74% C
Trailing 12 Months  
Capital Gain 34.40% 88% B+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.40% 86% B+ 72% C
Trailing 5 Years  
Capital Gain 99.37% 94% A 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 99.37% 94% A 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 15.46% 89% A- 77% C+
Dividend Return 15.46% 87% B+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.35% 39% F 77% C+
Risk Adjusted Return 100.76% 95% A 96% N/A
Market Capitalization 0.66B 69% C- 53% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.